B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Relaxin receptors

REACTOME PATHWAY
Reactome: R-HSA-4448212 genes18 compounds

The Relaxin receptors pathway (Reactome ID: R-HSA-444821) involves 2 genes and is affected by 18 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

RXFP1RXFP2

Compounds Affecting Relaxin receptors

#CompoundTargets HitStudies
12-Chloroadenosine 2-Chloroadenosine.300
2Methylene Blue200
3Aprepitant297
4Beclomethasone300
5Chlormadinone Acetate300
6Clotrimazole296
7Ethidium300
8Flunarizine Flunarizine is299
9Halcinonide88
10Hexachlorophene300
11oxatomide [Supplementary Concept] structure;128
12Oxymetholone298
13Oxyphenbutazone300
14rafoxanide172
15Rimonabant300
16Testosterone Propionate300
17Troglitazone299
18urolithin b49

About the Relaxin receptors Pathway

The Relaxin receptors pathway is catalogued in Reactome (ID: R-HSA-444821) and involves 2 genes. In the BiohacksAI corpus, 18 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include RXFP1, RXFP2.